- The trend backdrop is active with a 13-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
AYA
ASX
Week ended 07 Aug 2026
Weekly Investor Report
Artrya Limited · Healthcare · Health Information Services
Latest close
4.44 AUD
10.2%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 4.9% above the Trend Line and sits at 61.1% of its 52-week range. The latest completed week returned 10.2%, after a -23.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100.
Setup score
49
out of 100
Latest Close
4.44 AUD
7 Aug 2026
1W Return
10.2%
latest completed week
4W Return
-23.1%
short-term follow-through
12W Return
-12.1%
quarterly tape
Trend Breadth
82.7%
43 of 52 weeks active
Volume Ratio
1.7x
vs 13-week average
- 4 reversal markers appear in the recent smart-money tape.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
10.2%
Latest completed week; four-week move -23.1%.
Indicator stack
90/50
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
4 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 4.9% above the Trend Line and sits at 61.1% of its 52-week range. The latest completed week returned 10.2%, after a -23.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8212-week average 0.81
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.82Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers
No recent accumulation markers. 4 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -23.1% over four weeks, -12.1% over 12 weeks, and 241.5% over one year. The current trend has remained active for 13 consecutive weeks.
Performance by holding period
Active trend streak13 weeks
Active weeks in one year43
Trend breadth82.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.29Latest activity-pressure read.
Pressure change-69.3%Four-week change in activity pressure.
Leadership12.04Latest relative-leadership reading.
RS change-81.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 30 Jun 2025
Field coverage 67%
Model confidence 34%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength78/100Blend of value, momentum, and quality. Underlying universe rank 23; rank 1 is best.
Value71/100Relative valuation strength. Underlying universe rank 30; rank 1 is best.
Quality69/100Profitability and accounting quality. Underlying universe rank 32; rank 1 is best.
Momentum70/100Medium-term price momentum. Underlying universe rank 31; rank 1 is best.
Growth71/100Revenue and earnings growth. Underlying universe rank 30; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- - Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -2.0% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 100.0% Gross profit retained from each unit of revenue.
- Operating margin
- -78864.3% Operating profit retained from revenue.
- Free-cash-flow margin
- -51907.1% Free cash flow generated from revenue.
- Return on invested capital
- -156.5% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- - Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 3/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -2.6% Net share repurchases relative to market value.
- Shareholder yield
- -2.6% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.5x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 4 relevant articles.
0 positive · 4 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-31.6%Distance below the 52-week high.
13-week volatility12.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2612 weeks finished lower.
Best week+24.6%Week of 10 Apr.
Worst week-28.5%Week of 31 Jul.
Latest week+10.2%Week of 7 Aug.
Shape of recent returns
Strong gains12
Modest gains1
Flat weeks1
Modest losses4
Sharp losses8
Recent vol12.0%13-week weekly-return volatility.
Base vol12.0%52-week weekly-return volatility.
Up/down split31/20Count of positive and negative weeks in the 52-week window.
Average skew10.4% / -8.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAU Healthcare
4-week rank92 / 100
Group average-0.9%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD58.0%positive activity pressure
RS26.0%positive relative leadership
Four-week leaders
IndustryAU Health Information Services
4-week rank21 / 25
Group average-5.6%
Trend breadth28.0%
Trend28.0%active weekly trend signals
MD52.0%positive activity pressure
RS28.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape59/100
Trend, activity pressure, participation, and risk combine to a 59/100 tape read.
Indicator analysis80/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.82; 4 reversal markers Factors71/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 71; Small Cap Core rank 37 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 4 relevant articles.
Artrya Limited Actuals & Estimates (ASX:AYA) Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 4.44 AUD | 10.2% | 4.23 AUD | 1.56 AUD | 0.29 | 12.04 | 4.0M | On |
| 31 Jul 2026 | 4.03 AUD | -28.5% | 4.23 AUD | 1.53 AUD | 0.80 | 6.53 | 6.5M | On |
| 24 Jul 2026 | 5.64 AUD | 5.2% | 4.27 AUD | 1.51 AUD | 1.13 | 54.94 | 2.1M | On |
| 17 Jul 2026 | 5.36 AUD | -7.1% | 4.24 AUD | 1.47 AUD | 1.08 | 50.50 | 2.8M | On |
| 10 Jul 2026 | 5.77 AUD | -8.0% | 4.19 AUD | 1.44 AUD | 0.94 | 65.62 | 3.3M | On |
| 3 Jul 2026 | 6.27 AUD | 20.3% | 4.13 AUD | 1.41 AUD | 0.57 | 84.02 | 696.8K | On |
| 26 Jun 2026 | 5.21 AUD | 8.8% | 4.03 AUD | 1.37 AUD | 0.58 | 59.14 | 629.6K | On |
| 19 Jun 2026 | 4.79 AUD | 6.4% | 3.97 AUD | 1.33 AUD | 0.56 | 49.12 | 602.8K | On |
| 12 Jun 2026 | 4.50 AUD | -6.1% | 3.91 AUD | 1.30 AUD | 0.64 | 44.05 | 425.4K | On |
| 5 Jun 2026 | 4.79 AUD | -3.2% | 3.87 AUD | 1.28 AUD | 0.88 | 60.22 | 3.6M | On |
| 29 May 2026 | 4.95 AUD | 4.4% | 3.83 AUD | 1.25 AUD | 0.81 | 67.88 | 1.5M | On |
| 22 May 2026 | 4.74 AUD | -6.1% | 3.78 AUD | 1.22 AUD | 0.65 | 66.68 | 1.7M | On |
| 15 May 2026 | 5.05 AUD | 13.5% | 3.75 AUD | 1.19 AUD | 0.48 | 83.00 | 2.3M | On |
| 8 May 2026 | 4.45 AUD | 9.6% | 3.69 AUD | 1.16 AUD | 0.23 | 64.09 | 2.4M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.